Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 28, 2017
Decreased expression of TCF12 contributes to progression and predicts biochemical recurrence in patients with prostate cancerQing-Biao Chen, Ying-Ke Liang, Yan-Qiong Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 23, 2016
Protein regulator of cytokinesis 1 overexpression predicts biochemical recurrence in men with prostate cancerHong-Wei Luo, Qing-Biao Chen, Yue-Ping Wan, et al.
Oncotarget|November 9, 2017
Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activationMin-Yao Jiang, Zhao-Dong Han, Wenjiao Li, et al.
Medical Oncology (Northwood, London, England)|November 13, 2008
Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancerHui-chan He, Xue-cheng Bi, Zhi-wei Zheng, et al.
Cancer Science|July 12, 2021
Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinomaHai-Bo Zhao, Yan-Ru Zeng, Zhao-Dong Han, et al.
Clinical and Experimental Medicine|January 14, 2010
CK20 and Ki-67 as significant prognostic factors in human bladder carcinomaYong-kang Ye, Xue-cheng Bi, Hui-chan He, et al.
Oncotargets and Therapy|May 5, 2016
Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancerXin Fu, Guo Chen, Zhi-Duan Cai, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 15, 2014
MicroRNA-224 and its target CAMKK2 synergistically influence tumor progression and patient prognosis in prostate cancerHao Fu, Hui-chan He, Zhao-dong Han, et al.
Oncotargets and Therapy|February 5, 2014
Combined overexpression of HIVEP3 and SOX9 predicts unfavorable biochemical recurrence-free survival in patients with prostate cancerGuo-Qiang Qin, Hui-Chan He, Zhao-Dong Han, et al.
Oncology Reports|March 28, 2015
Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancerYu-Xiang Liang, Ru-Jun Mo, Hui-Chan He, et al.
Pageof 6